6 Depression is strongly associated with the development of type 2 diabetes and inversely associated with insulin sensitivity. Program (RGJ‐Ph.D. I have read and accept the Wiley Online Library Terms and Conditions of UsePsychopharmacological prescriptions for people with autism spectrum disorder (ASD): a multinational studyUse of antipsychotic medications in pediatric populations: what do the data say?Atypical antipsychotic use in the treatment of psychosis in primary careHyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone9‐Hydroxyrisperidone‐induced hyperprolactinaemia in Thai children and adolescents with autism spectrum disorderImpact of pharmacogenetic markers of CYP2D6 and DRD2 on prolactin response in risperidone‐treated Thai children and adolescents with autism spectrum disordersHyperuricemia in children and adolescents with autism spectrum disorder treated with risperidone: the risk factors for metabolic adverse effectsEffectiveness, adverse effects and drug compliance of long‐acting injectable risperidone in children and adolescentsIncreased risk of obesity and metabolic dysregulation following 12 months of second‐generation antipsychotic treatment in children: a prospective cohort studyAntipsychotics‐induced metabolic alterations: focus on adipose tissue and molecular mechanismsChange in metabolic parameters and weight in response to risperidone monotherapy in young children with nonpsychotic disorders: a prospective open‐label studyCytochrome P450 2D6 genotype and steady state plasma levels of risperidone and 9‐hydroxyrisperidoneUpdate on allele nomenclature for human cytochromes P450 and the Human Cytochrome P450 Allele (CYP‐allele) Nomenclature DatabasePharmacogenetics of risperidone: a systematic review of the clinical effects of CYP2D6 polymorphismsPharmacogenetics of risperidone and cardiovascular risk in children and adolescentsRole of P‐glycoprotein in pharmacokinetics: clinical implicationsThe role of CYP2D6 and ABCB1 pharmacogenetics in drug‐naive patients with first‐episode schizophrenia treated with risperidonePsychopharmacology of atypical antipsychotic drugs: from the receptor binding profile to neuroprotection and neurogenesisDisruption of the dopamine d2 receptor impairs insulin secretion and causes glucose intoleranceD2 dopamine receptor Taq1A polymorphism, body weight, and dietary intake in type 2 diabetesLeptin therapy, insulin sensitivity, and glucose homeostasisGhrelin in Type 2 diabetes mellitus and metabolic syndromeBrain‐derived neurotrophic factor (BDNF) and type 2 diabetesThe effects of brain‐derived neurotrophic factor on insulin signal transduction in the liver of diabetic micePhysiology of leptin: energy homeostasis, neuroendocrine function and metabolismEffects of second generation antipsychotics on leptin and ghrelinPolymorphism of the leptin gene promoter in pedigrees of type 2 diabetes mellitus in Chongqing, ChinaRelationship between leptin G2548A and leptin receptor Q223R gene polymorphisms and obesity and metabolic syndrome risk in Tunisian volunteersAssociation studies on ghrelin and ghrelin receptor gene polymorphisms with obesityNeurotrophism and energy homeostasis: perfect togetherBrain‐derived neurotrophic factor and tyrosine kinase receptor TrkB in rat brain are significantly altered after haloperidol and risperidone administrationAssociation study of Val66Met polymorphism in brain‐derived neurotrophic factor gene with clozapine‐induced metabolic syndrome: preliminary resultsMolecular genetic analysis of CYP2D6 and HLA‐B*15:02 in Thai autistic spectrum disorder children: implication for pharmacogenetics testing and optimization of drug treatmentsImpact of CYP2D6 polymorphism on steady‐state plasma levels of risperidone and 9‐hydroxyrisperidone in Thai children and adolescents with autism spectrum disorderThe CYP2D6 activity score: translating genotype information into a qualitative measure of phenotypeClinical pharmacogenetics implementation consortium guideline for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressantsCytochrome P450 2D6 genotype affects the pharmacokinetics of controlled‐release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systemsDevelopment and validation of liquid chromatography/tandem mass spectrometry analysis for therapeutic drug monitoring of risperidone and 9‐hydroxyrisperidone in pediatric patients with autism spectrum disordersHealthy chilean adolescents with HOMA‐IR >/= 2.6 have increased cardiometabolic risk: association with genetic, biological, and environmental factorsDiabetes mellitus and impaired glucose tolerance in patients with schizophrenia, before and after antipsychotic treatmentPrevalence of diabetes and impaired glucose tolerance in patients treated with clozapine compared with patients treated with conventional depot neuroleptic medicationsAntipsychotics and diabetes: an age‐related associationDetection of CYP2D6 polymorphism using Luminex xTAG technology in autism spectrum disorder: CYP2D6 activity score and its association with risperidone levelsThe CYP2D6 poor metabolizer phenotype may be associated with risperidone adverse drug reactions and discontinuationPharmacogenetics and clinical risk factors for risperidone‐related weight gain in Thai autistic spectrum disorder patientsPrediction of CYP2D6 phenotype from genotype across world populationsEffects of various factors on steady‐state plasma concentrations of risperidone and 9‐hydroxyrisperidone: lack of impact of MDR‐1 genotypesCYP2D6 genotyping in paediatric patients with autism treated with risperidone: a preliminary cohort studyRisperidone in schizophrenia: is there a role for therapeutic drug monitoring?Brain‐derived neurotrophic factor regulates glucose metabolism by modulating energy balance in diabetic miceCellular localization of the Trk neurotrophin receptor family in human non‐neuronal tissuesThe BDNF val66met polymorphism affects activity‐dependent secretion of BDNF and human memory and hippocampal functionThe influence of the brain‐derived neurotropic factor Val66Met genotype and HMG‐CoA reductase inhibitors on insulin resistance in the schizophrenia and bipolar populationsPlasma triglyceride/HDL‐cholesterol ratio, insulin resistance, and cardiometabolic risk in young adultsThe brain‐derived neurotrophic factor (BDNF) Val66Met polymorphism is associated with increased body mass index and insulin resistance measures in bipolar disorder and schizophreniaInsulin resistance and hyperglycaemia in cardiovascular disease developmentLeptin deficiency causes insulin resistance induced by uncontrolled diabetesLeptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophySOCS3 and SOCS6 are required for the risperidone‐mediated inhibition of insulin and leptin signaling in neuroblastoma cellsA polymorphism in the leptin promoter region (‐2548 G/A) influences gene expression and adipose tissue secretion of leptinAssociation between 5‐HTR2C ‐759C/T (rs3813929) and ‐697G/C (rs518147) gene polymorphisms and risperidone‐induced insulin resistance syndrome in an indian populationInsulin resistance in children: consensus, perspective, and future directionsMeasurement of insulin sensitivity in children: comparison between the euglycemic‐hyperinsulinemic clamp and surrogate measuresNrf2 Antioxidative System is Involved in Cytochrome P450 Gene Expression and Activity: A Delay in Pentobarbital Metabolism in Nrf2-Deficient Mice, Pharmacogenomics of drugs used to treat brain disorders, Expert Review of Precision Medicine and Drug Development, Menaquinone-4 Accelerates Calcification of Human Aortic Valve Interstitial Cells in High-Phosphate Medium through PXR, Journal of Pharmacology and Experimental Therapeutics, Pharmacogenetics biomarkers of antipsychotics’ safety in adolescents with acute psychotic episode, V.M.